AIHC Capital Management Ltd
An institutional investment manager in CENTRAL. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 2103725.
- Reported value$104.2m
- Positions4
Holdings: 4 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Revolution Medicines IncRVMD | COM | 76155X100 | 56.8 | 54.5% | 303,133 | Reduced−525,841 | |
| Oric Pharmaceuticals IncORIC | COM | 68622P109 | 41.5 | 39.8% | 3,828,460 | Added+1,368,909 | |
| Novabridge BiosciencesNBP | SPONSORED ADS | 44975P103 | 5.6 | 5.4% | 2,878,033 | Added+615,100 | |
| Korro Bio IncKRRO | COM | 500946108 | 0.4 | 0.4% | 30,265 | Unchanged |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 0.0 | 0.0% | 0 | Sold out−51,402 |
Source: SEC EDGAR, Form 13F-HR, accession 0001172661-26-003381 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.